A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.
about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disordersLet-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell lineCharacterization of extracellular circulating microRNAExtracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionThe role of microRNAs in bladder cancerAberrantly expressed microRNAs in the context of bladder tumorigenesisBiomarkers for non-muscle invasive bladder cancer: Current tests and future promiseDiagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-AnalysisExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsThe circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluidsMicroRNAs and triple negative breast cancerExtracellular microRNAs in urologic malignancies: chances and challengesMicroRNAs as biomarkers for myocardial infarctionClinical and pathological implications of miRNA in bladder cancerIntercellular transport of microRNAsMicroRNAs Related to Polycystic Ovary Syndrome (PCOS)MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potentialIdentification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot studyDetection of circulating parasite-derived microRNAs in filarial infectionsExport of microRNAs and microRNA-protective protein by mammalian cellsThe microRNA spectrum in 12 body fluidsUrinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancermiR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinomaPotential new urinary markers in the early detection of bladder cancer.Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedureCell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.MicroRNAs in biofluids are novel tools for bladder cancer screening.Strengths and limitations of laboratory procedures for microRNA detectionA knowledge base for the discovery of function, diagnostic potential and drug effects on cellular and extracellular miRNAsCell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancerMicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.Comprehensive reconstruction and visualization of non-coding regulatory networks in human.Serum microRNA profiles in children with autism.MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis.Noninvasive micromarkersElevated levels of miR-155 in blood and urine from patients with nephrolithiasis.miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.MicroRNAs as biomarkers in colorectal cancer
P2860
Q21129476-FDB2E114-D6D1-489A-B464-2B35EF5FA6A5Q21136096-1586F62C-B758-40DF-918A-50C3B609221BQ24603537-28133EF0-7A81-4680-94A9-098092B97FF5Q26742027-8DA86A67-6230-4075-88C4-7FD6BD94D663Q26744149-DBDA51CF-B702-41BD-83E5-758A7D8DA826Q26744152-331F5EFE-5254-481E-BC59-798920ECDE89Q26775990-25307B57-972D-4FD1-864D-FB415357EB8FQ26786185-FE675372-FE8F-41EA-88F2-0F9D988AEF70Q26796590-D03FAA0A-8ECE-4B47-B0B8-281CCCB08EB3Q26825022-3303433E-3CD9-4E43-A18E-94B806CA12D0Q26862716-82FBFB8A-469D-4A73-8D21-E763F789DBC9Q26866043-A53D027E-D458-4F3B-A600-EA12312B0FF1Q27000432-CDBE12C1-75F4-4FD3-A072-91DD038D1D27Q27004262-3F25DA85-CD90-488B-BCD5-AF6E369408D4Q27004360-10B5D03B-E571-4190-8563-72840A6FAC67Q27025580-8547462A-4A8C-4FB6-A061-5D1148162B7AQ28081081-F7B4CFEF-1588-477A-BD98-8B78FB1A1E4BQ28395462-96B276AA-9F75-4EB0-9BD7-706639E6AA1FQ28655587-00F6FA35-DBBB-47FB-B726-4445E67A56CCQ29614234-89E9298D-20E8-4628-9D8B-B36CD8604EF0Q29618068-DC450FF5-EAF5-44C5-B9FA-8E37244AC14CQ33566895-40E3A763-D88B-4680-8ACD-6D01BE16EF9DQ33653161-17AB44F6-A8A6-466A-9612-8D00A8E4825DQ33657098-BD451F3F-9F48-40C4-886A-2A16542F395DQ33689126-B71EC1AE-17E6-4A7E-906A-1211F4843891Q33732120-65762CD6-7448-463E-9FC4-B8FB3761910BQ33750895-74B09824-6B80-4C06-BFB8-CCBDBEE687F0Q33762123-3FF739FA-8B02-46B1-AF31-FD7967E8FDA9Q33780712-75EA7644-AEC9-409E-94B3-76521CE39958Q33851551-0F0EABE7-3447-45DC-9D12-CDE871FEBF66Q33889872-EDD40640-15E6-4C3E-9867-361776542930Q33962495-6088021B-DD38-47D1-B66D-5CA79A9C79B4Q34039254-65C2C346-D7AF-486C-A200-369610705097Q34042865-7E9E7EA7-F62D-49EF-9A1C-604C92CA2DAEQ34043327-B82CBA19-6D3C-4C46-9492-D60B6FE1AC4DQ34078121-DA69D458-1A9B-4C98-B76C-DFDFFE781384Q34111606-2C9A7DDF-B2F6-42CF-BF5C-8494B32901B3Q34114226-A2975BAE-AA69-4D34-B8AF-58BED5A78580Q34157084-7EB7FE92-3576-4C49-B9AE-EEF8A2F7CD66Q34162262-D402C272-8694-4C35-914E-F69FF3E86FCA
P2860
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A robust methodology to study ...... ted to urinary bladder cancer.
@ast
A robust methodology to study ...... ted to urinary bladder cancer.
@en
A robust methodology to study ...... ted to urinary bladder cancer.
@nl
type
label
A robust methodology to study ...... ted to urinary bladder cancer.
@ast
A robust methodology to study ...... ted to urinary bladder cancer.
@en
A robust methodology to study ...... ted to urinary bladder cancer.
@nl
prefLabel
A robust methodology to study ...... ted to urinary bladder cancer.
@ast
A robust methodology to study ...... ted to urinary bladder cancer.
@en
A robust methodology to study ...... ted to urinary bladder cancer.
@nl
P2093
P1433
P1476
A robust methodology to study ...... ted to urinary bladder cancer.
@en
P2093
Alfred C Feller
Dieter Jocham
Georg Sczakiel
Hartmut Merz
Ingo Kausch
Jens M Warnecke
Kai Hoefig
Merle Hanke
P304
P356
10.1016/J.UROLONC.2009.01.027
P577
2009-04-17T00:00:00Z